Hypoxic adipocytes pattern early heterotopic bone formation

被引:132
作者
Olmsted-Davis, Elizabeth
Gannon, Francis H.
Ozen, Mustafa
Ittmann, Michael M.
Gugala, Zbigniew
Hipp, John A.
Moran, Kevin M.
Fouletier-Dilling, Christine M.
Schumara-Martin, Shannon
Lindsey, Ronald W.
Heggeness, Michael H.
Brenner, Malcolm K.
Davis, Alan R.
机构
[1] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Orthoped Surg, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[5] Univ Texas, Med Branch, Dept Orthoped & Rehabil, Galveston, TX 77550 USA
[6] Armed Forces Inst Pathol, Dept Bone Biol, Washington, DC 20306 USA
关键词
D O I
10.2353/ajpath.2007.060692
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
The factors contributing to heterotopic ossification, the formation of bone in abnormal soft-tissue locations, are beginning to emerge, but little is known about microenvironmental conditions promoting this often devastating disease. Using a murine model in which endochondral bone formation is triggered in muscle by bone morphogenetic protein 2 (BMP2), we studied changes near the site of injection of BMP2-expressing cells. As early as 24 hours later, brown adipocytes began accumulating in the lesional area. These cells stained positively for pimonidazole and therefore generated hypoxic stress within the target tissue, a prerequisite for the differentiation of stem cells to chondrocytes and subsequent heterotopic bone formation. We propose that aberrant expression of BMPs in soft tissue stimulates production of brown adipocytes, which drive the early steps of heterotopic endochondral ossification by lowering oxygen tension in adjacent tissue, creating the correct environment for chondrogenesis. Results in misty gray lean mutant mice not producing brown fat suggest that white adipocytes convert into fat-oxidizing cells when brown adipocytes are unavailable, providing a compensatory mechanism for generation of a hypoxic microenvironment. Manipulation of the transcriptional control of adipocyte fate in local soft-tissue environments may offer a means to prevent or treat development of bone in extraskeletal sites.
引用
收藏
页码:620 / 632
页数:13
相关论文
共 54 条
[1]
Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis [J].
Ahn, J ;
de la Peña, LS ;
Shore, EM ;
Kaplan, FS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A (04) :667-674
[2]
Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203
[3]
Brown adipose tissue: Function and physiological significance [J].
Cannon, B ;
Nedergaard, J .
PHYSIOLOGICAL REVIEWS, 2004, 84 (01) :277-359
[4]
Cao BH, 2004, CELL CYCLE, V3, P104
[5]
Comparison insight bone measurements by histomorphometry and μCT [J].
Chappard, D ;
Retailleau-Gaborit, N ;
Legrand, E ;
Baslé, MF ;
Audran, M .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) :1177-1184
[6]
Current concepts of molecular aspects of bone healing [J].
Dimitriou, R ;
Tsiridis, E ;
Giannoudis, PV .
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2005, 36 (12) :1392-1404
[7]
Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation [J].
Dominici, M ;
Pritchard, C ;
Garlits, JE ;
Hofmann, TJ ;
Persons, DA ;
Horwitz, EM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (32) :11761-11766
[8]
Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
[9]
Evidence for an evolutionary conserved role of bone morphogenetic protein growth factors and Phox2 transcription factors during noradrenergic differentiation of sympathetic neurons - Induction of a putative synexpression group of neurotransmitter-synthesizing enzymes [J].
Ernsberger, U .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (24) :6976-6981
[10]
Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor [J].
Fouletier-Dilling, CM ;
Bosch, P ;
Davis, AR ;
Shafer, JA ;
Stice, SL ;
Gugala, Z ;
Gannon, FH ;
Olmsted-Davis, EA .
HUMAN GENE THERAPY, 2005, 16 (11) :1287-1297